Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lenses, Intraocular | 31 | 2024 | 403 | 4.700 |
Why?
|
| Phacoemulsification | 23 | 2024 | 243 | 3.890 |
Why?
|
| Lens Implantation, Intraocular | 29 | 2024 | 349 | 3.630 |
Why?
|
| Cornea | 22 | 2024 | 685 | 3.430 |
Why?
|
| Astigmatism | 13 | 2020 | 185 | 3.040 |
Why?
|
| Refraction, Ocular | 26 | 2024 | 316 | 2.840 |
Why?
|
| Corneal Topography | 17 | 2024 | 204 | 2.770 |
Why?
|
| Myopia | 11 | 2024 | 194 | 1.990 |
Why?
|
| Optics and Photonics | 11 | 2024 | 143 | 1.750 |
Why?
|
| Biometry | 15 | 2024 | 143 | 1.750 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 10 | 2018 | 105 | 1.730 |
Why?
|
| Cataract Extraction | 7 | 2024 | 221 | 1.680 |
Why?
|
| Visual Acuity | 27 | 2024 | 869 | 1.560 |
Why?
|
| Axial Length, Eye | 9 | 2024 | 49 | 1.410 |
Why?
|
| Ophthalmology | 5 | 2024 | 217 | 1.050 |
Why?
|
| Cataract | 7 | 2024 | 230 | 1.030 |
Why?
|
| Cytomegalovirus Retinitis | 5 | 2013 | 16 | 0.930 |
Why?
|
| AIDS-Related Opportunistic Infections | 5 | 2013 | 138 | 0.870 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2013 | 268 | 0.860 |
Why?
|
| Corneal Diseases | 3 | 2019 | 107 | 0.850 |
Why?
|
| Academies and Institutes | 4 | 2024 | 88 | 0.830 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2020 | 35 | 0.800 |
Why?
|
| Corneal Injuries | 2 | 2024 | 37 | 0.800 |
Why?
|
| Keratoconus | 3 | 2023 | 73 | 0.790 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2021 | 55 | 0.740 |
Why?
|
| Photorefractive Keratectomy | 6 | 2021 | 81 | 0.740 |
Why?
|
| Refractive Surgical Procedures | 4 | 2024 | 77 | 0.730 |
Why?
|
| Refractive Errors | 4 | 2018 | 86 | 0.720 |
Why?
|
| Corneal Wavefront Aberration | 3 | 2024 | 20 | 0.720 |
Why?
|
| Iris Diseases | 2 | 2024 | 15 | 0.720 |
Why?
|
| Corneal Pachymetry | 4 | 2018 | 27 | 0.710 |
Why?
|
| Eye Diseases | 2 | 2024 | 138 | 0.660 |
Why?
|
| Ophthalmic Solutions | 2 | 2019 | 94 | 0.650 |
Why?
|
| Serum | 1 | 2019 | 46 | 0.630 |
Why?
|
| Anterior Eye Segment | 2 | 2017 | 31 | 0.630 |
Why?
|
| Multifocal Intraocular Lenses | 2 | 2017 | 14 | 0.620 |
Why?
|
| Microsurgery | 2 | 2012 | 72 | 0.610 |
Why?
|
| Eye Foreign Bodies | 1 | 2018 | 15 | 0.580 |
Why?
|
| Interferometry | 2 | 2017 | 28 | 0.570 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 51 | 0.560 |
Why?
|
| Corneal Ulcer | 1 | 2018 | 57 | 0.560 |
Why?
|
| Models, Anatomic | 1 | 2018 | 104 | 0.550 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 92 | 0.550 |
Why?
|
| Keratomileusis, Laser In Situ | 5 | 2024 | 149 | 0.540 |
Why?
|
| Humans | 76 | 2024 | 133937 | 0.510 |
Why?
|
| Tomography, Optical Coherence | 9 | 2024 | 586 | 0.500 |
Why?
|
| Dry Eye Syndromes | 1 | 2019 | 281 | 0.490 |
Why?
|
| Acanthamoeba Keratitis | 2 | 2021 | 17 | 0.470 |
Why?
|
| Keratotomy, Radial | 2 | 2016 | 33 | 0.470 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 3056 | 0.460 |
Why?
|
| Prospective Studies | 19 | 2024 | 6664 | 0.460 |
Why?
|
| Retrospective Studies | 28 | 2024 | 17488 | 0.450 |
Why?
|
| Middle Aged | 32 | 2024 | 29409 | 0.440 |
Why?
|
| Descemet Membrane | 2 | 2012 | 16 | 0.420 |
Why?
|
| Pseudophakia | 4 | 2024 | 75 | 0.420 |
Why?
|
| Epithelium, Corneal | 4 | 2024 | 176 | 0.410 |
Why?
|
| Iris | 5 | 2024 | 65 | 0.400 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2012 | 9 | 0.400 |
Why?
|
| Lasers, Excimer | 4 | 2021 | 101 | 0.380 |
Why?
|
| Hyperopia | 3 | 2021 | 83 | 0.350 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 7212 | 0.350 |
Why?
|
| Aged | 21 | 2024 | 21746 | 0.340 |
Why?
|
| Corneal Stroma | 3 | 2021 | 102 | 0.320 |
Why?
|
| Suture Techniques | 6 | 2017 | 202 | 0.320 |
Why?
|
| Male | 37 | 2024 | 65902 | 0.300 |
Why?
|
| Female | 37 | 2024 | 71682 | 0.290 |
Why?
|
| Functional Laterality | 1 | 2008 | 197 | 0.270 |
Why?
|
| Prosthesis Design | 6 | 2024 | 711 | 0.270 |
Why?
|
| Adult | 22 | 2024 | 31949 | 0.270 |
Why?
|
| Aberrometry | 2 | 2024 | 12 | 0.260 |
Why?
|
| Antiprotozoal Agents | 2 | 2021 | 42 | 0.250 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 297 | 0.240 |
Why?
|
| Eye | 2 | 2024 | 246 | 0.240 |
Why?
|
| Eye Burns | 1 | 2024 | 16 | 0.230 |
Why?
|
| Organ Size | 2 | 2018 | 466 | 0.230 |
Why?
|
| Amnion | 1 | 2024 | 40 | 0.230 |
Why?
|
| Burns, Chemical | 1 | 2024 | 31 | 0.220 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2013 | 239 | 0.220 |
Why?
|
| Uveitis | 2 | 2011 | 38 | 0.220 |
Why?
|
| Ectopia Lentis | 3 | 2015 | 12 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 506 | 0.220 |
Why?
|
| Sclera | 2 | 2014 | 58 | 0.210 |
Why?
|
| Ganciclovir | 1 | 2013 | 105 | 0.200 |
Why?
|
| Retinopathy of Prematurity | 2 | 2016 | 64 | 0.200 |
Why?
|
| Phosphorylcholine | 1 | 2021 | 25 | 0.190 |
Why?
|
| Wound Healing | 3 | 2012 | 495 | 0.190 |
Why?
|
| Keratitis | 2 | 2021 | 116 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 139 | 0.180 |
Why?
|
| Artificial Lens Implant Migration | 2 | 2018 | 9 | 0.180 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2011 | 5 | 0.180 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 31 | 0.180 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3227 | 0.180 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 28 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 37 | 0.180 |
Why?
|
| Fourier Analysis | 2 | 2018 | 61 | 0.170 |
Why?
|
| Treatment Outcome | 12 | 2024 | 13013 | 0.170 |
Why?
|
| Ligaments | 1 | 2020 | 21 | 0.170 |
Why?
|
| United States | 8 | 2024 | 11687 | 0.160 |
Why?
|
| Amblyopia | 1 | 2019 | 32 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 243 | 0.150 |
Why?
|
| Lens, Crystalline | 2 | 2018 | 144 | 0.150 |
Why?
|
| Preservation, Biological | 1 | 2018 | 10 | 0.150 |
Why?
|
| China | 1 | 2019 | 295 | 0.150 |
Why?
|
| Intraoperative Complications | 2 | 2017 | 175 | 0.150 |
Why?
|
| Light | 2 | 2017 | 187 | 0.150 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 5511 | 0.150 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 39 | 0.140 |
Why?
|
| Photography | 2 | 2015 | 101 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 3475 | 0.140 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2017 | 14 | 0.140 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2017 | 20 | 0.140 |
Why?
|
| Eyelids | 1 | 2018 | 119 | 0.140 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 345 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2013 | 825 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2017 | 97 | 0.130 |
Why?
|
| Anterior Chamber | 1 | 2017 | 58 | 0.130 |
Why?
|
| Collagen | 1 | 2018 | 334 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2018 | 397 | 0.130 |
Why?
|
| Term Birth | 1 | 2016 | 35 | 0.130 |
Why?
|
| Reference Standards | 1 | 2017 | 245 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 417 | 0.120 |
Why?
|
| Retinal Detachment | 2 | 2010 | 87 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 153 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 157 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2018 | 525 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2016 | 133 | 0.110 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 50 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 317 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2018 | 571 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1335 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1076 | 0.110 |
Why?
|
| gamma-Linolenic Acid | 1 | 2013 | 3 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 693 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 621 | 0.100 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 2013 | 43 | 0.100 |
Why?
|
| Tears | 2 | 2013 | 176 | 0.100 |
Why?
|
| Young Adult | 7 | 2019 | 9889 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 619 | 0.100 |
Why?
|
| Corneal Surgery, Laser | 1 | 2013 | 22 | 0.100 |
Why?
|
| Postoperative Period | 3 | 2018 | 353 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2013 | 75 | 0.100 |
Why?
|
| Endothelium, Corneal | 1 | 2012 | 45 | 0.100 |
Why?
|
| Vitrectomy | 2 | 2010 | 112 | 0.100 |
Why?
|
| Intraocular Pressure | 1 | 2013 | 151 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 153 | 0.100 |
Why?
|
| Cell Count | 1 | 2012 | 254 | 0.090 |
Why?
|
| Disease Management | 1 | 2016 | 561 | 0.090 |
Why?
|
| Microscopy, Acoustic | 2 | 2024 | 17 | 0.090 |
Why?
|
| Premature Birth | 1 | 2016 | 417 | 0.090 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 16 | 0.090 |
Why?
|
| Meibomian Glands | 1 | 2011 | 44 | 0.090 |
Why?
|
| Pupil Disorders | 1 | 2010 | 20 | 0.090 |
Why?
|
| Risk Factors | 5 | 2017 | 11100 | 0.090 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 75 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2017 | 1066 | 0.080 |
Why?
|
| Aphakia, Postcataract | 3 | 2017 | 22 | 0.080 |
Why?
|
| Physical Examination | 1 | 2010 | 164 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2010 | 234 | 0.080 |
Why?
|
| Sjogren's Syndrome | 1 | 2011 | 98 | 0.080 |
Why?
|
| Viral Load | 2 | 2011 | 412 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 132 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2021 | 14800 | 0.080 |
Why?
|
| Child | 9 | 2021 | 25739 | 0.070 |
Why?
|
| Benzamidines | 1 | 2008 | 10 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 1002 | 0.070 |
Why?
|
| Vision, Binocular | 1 | 2008 | 48 | 0.070 |
Why?
|
| Contact Lenses | 1 | 2008 | 45 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 505 | 0.070 |
Why?
|
| Adolescent | 7 | 2016 | 20534 | 0.070 |
Why?
|
| Time Factors | 4 | 2019 | 6590 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1250 | 0.070 |
Why?
|
| Neurons | 1 | 2016 | 2035 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2519 | 0.060 |
Why?
|
| Re-Epithelialization | 1 | 2024 | 12 | 0.060 |
Why?
|
| Disease Progression | 2 | 2011 | 2242 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2024 | 32 | 0.050 |
Why?
|
| Corneal Neovascularization | 1 | 2003 | 13 | 0.050 |
Why?
|
| Prednisolone | 1 | 2003 | 75 | 0.050 |
Why?
|
| Lasers | 1 | 2024 | 118 | 0.050 |
Why?
|
| Drug Implants | 1 | 2013 | 44 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 263 | 0.050 |
Why?
|
| Lissamine Green Dyes | 2 | 2013 | 8 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2013 | 156 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2013 | 145 | 0.050 |
Why?
|
| Loteprednol Etabonate | 1 | 2021 | 5 | 0.050 |
Why?
|
| Visual Fields | 1 | 2013 | 151 | 0.050 |
Why?
|
| Drug Substitution | 1 | 2021 | 20 | 0.050 |
Why?
|
| United States Public Health Service | 1 | 2011 | 5 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2003 | 212 | 0.050 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 27 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 2654 | 0.040 |
Why?
|
| Swine | 1 | 2024 | 1216 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 371 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2013 | 3639 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2011 | 395 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 96 | 0.040 |
Why?
|
| Hospitals, County | 1 | 2017 | 24 | 0.040 |
Why?
|
| Vision Tests | 1 | 2017 | 36 | 0.030 |
Why?
|
| Contrast Sensitivity | 1 | 2017 | 62 | 0.030 |
Why?
|
| HIV-1 | 1 | 2011 | 487 | 0.030 |
Why?
|
| Spiral Ganglion | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 2163 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1484 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 616 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2010 | 1596 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2296 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1494 | 0.030 |
Why?
|
| Tomography | 1 | 2015 | 41 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 286 | 0.030 |
Why?
|
| Neuroglia | 1 | 2016 | 217 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 2807 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1814 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 3402 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 40 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 81 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1694 | 0.030 |
Why?
|
| Retinoscopy | 1 | 2012 | 10 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 188 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2012 | 5182 | 0.020 |
Why?
|
| Rupture | 1 | 2012 | 34 | 0.020 |
Why?
|
| Nylons | 1 | 2012 | 13 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 31 | 0.020 |
Why?
|
| Conjunctiva | 1 | 2013 | 199 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 1217 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2940 | 0.020 |
Why?
|
| Sutures | 1 | 2012 | 67 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 81 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 480 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1667 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 5081 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 72 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2656 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3739 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 13161 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4547 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1736 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 1302 | 0.010 |
Why?
|
| Corneal Edema | 1 | 2003 | 14 | 0.010 |
Why?
|
| Ofloxacin | 1 | 2003 | 32 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 6296 | 0.010 |
Why?
|
| Animals | 1 | 2024 | 36387 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 269 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2003 | 406 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 3989 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 1197 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8591 | 0.010 |
Why?
|